Amgen And Syapse Enter Precision Medicine Collaboration In Oncology

Supports Providers With Advanced Insight Tools and Research Opportunities Generates Insights From Real-World Evidence for Potential Use in Regulatory Filings THOUSAND OAKS, Calif. and SAN FRANCISCO, May 2, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN), a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, today announced a precision medicine collaboration in oncology. Under the terms of the agreement, Amgen and Syapse will develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology. This effort will identify existing patients within the Syapse Learning Health Network th...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news